Ameritas Investment Partners Inc. raised its stake in shares of HealthSouth Corp (NYSE:HLS) by 7.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 37,249 shares of the company’s stock after acquiring an additional 2,600 shares during the quarter. Ameritas Investment Partners Inc.’s holdings in HealthSouth were worth $1,704,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. First Mercantile Trust Co. boosted its stake in HealthSouth by 18.8% during the 2nd quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after acquiring an additional 430 shares during the last quarter. Acrospire Investment Management LLC boosted its stake in HealthSouth by 64.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock valued at $136,000 after acquiring an additional 1,100 shares during the last quarter. Advisor Group Inc. boosted its stake in HealthSouth by 33.8% during the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after acquiring an additional 781 shares during the last quarter. Petrus Trust Company LTA bought a new position in HealthSouth during the 2nd quarter valued at $210,000. Finally, HL Financial Services LLC bought a new position in HealthSouth during the 2nd quarter valued at $213,000. Hedge funds and other institutional investors own 93.37% of the company’s stock.

HLS has been the topic of a number of research analyst reports. Royal Bank of Canada reiterated a “buy” rating on shares of HealthSouth in a research note on Wednesday, November 15th. ValuEngine downgraded shares of HealthSouth from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Mizuho upgraded shares of HealthSouth from a “neutral” rating to a “buy” rating and set a $55.00 price target on the stock in a research report on Thursday, November 2nd. Stephens initiated coverage on shares of HealthSouth in a research report on Thursday, August 31st. They issued an “overweight” rating and a $53.00 price target on the stock. Finally, Zacks Investment Research downgraded shares of HealthSouth from a “buy” rating to a “hold” rating in a research report on Tuesday, October 31st. Two analysts have rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $51.75.

In other news, Director Yvonne M. Curl acquired 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The shares were purchased at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the transaction, the director now directly owns 64,144 shares in the company, valued at approximately $2,947,416.80. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.60% of the company’s stock.

HealthSouth Corp (HLS) traded up $0.54 during trading on Wednesday, hitting $49.37. 554,800 shares of the stock were exchanged, compared to its average volume of 900,358. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34. HealthSouth Corp has a one year low of $38.24 and a one year high of $50.41. The company has a market cap of $4,800.52, a P/E ratio of 17.50, a P/E/G ratio of 1.80 and a beta of 0.54.

HealthSouth (NYSE:HLS) last issued its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The firm had revenue of $995.60 million for the quarter, compared to the consensus estimate of $985.75 million. HealthSouth had a net margin of 6.69% and a return on equity of 22.81%. HealthSouth’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the firm posted $0.65 EPS. equities analysts expect that HealthSouth Corp will post 2.72 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Tuesday, January 2nd will be given a $0.25 dividend. The ex-dividend date is Friday, December 29th. This represents a $1.00 annualized dividend and a yield of 2.03%. HealthSouth’s dividend payout ratio is presently 36.36%.

WARNING: This report was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.watchlistnews.com/healthsouth-corp-hls-shares-bought-by-ameritas-investment-partners-inc/1761378.html.

HealthSouth Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp (NYSE:HLS).

Institutional Ownership by Quarter for HealthSouth (NYSE:HLS)

Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with MarketBeat.com's FREE daily email newsletter.